1-109628209-C-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BS1_SupportingBS2
The NM_001368809.2(AMPD2):c.1207C>T(p.Arg403Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000651 in 1,614,004 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001368809.2 missense
Scores
Clinical Significance
Conservation
Publications
- pontocerebellar hypoplasia type 9Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics
- hereditary spastic paraplegia 63Inheritance: Unknown, AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001368809.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AMPD2 | NM_001368809.2 | MANE Select | c.1207C>T | p.Arg403Trp | missense | Exon 11 of 19 | NP_001355738.1 | ||
| AMPD2 | NM_004037.9 | c.1207C>T | p.Arg403Trp | missense | Exon 10 of 18 | NP_004028.4 | |||
| AMPD2 | NM_001308170.1 | c.1144C>T | p.Arg382Trp | missense | Exon 9 of 17 | NP_001295099.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AMPD2 | ENST00000528667.7 | TSL:1 MANE Select | c.1207C>T | p.Arg403Trp | missense | Exon 11 of 19 | ENSP00000436541.2 | ||
| AMPD2 | ENST00000342115.8 | TSL:1 | c.1126C>T | p.Arg376Trp | missense | Exon 10 of 18 | ENSP00000345498.4 | ||
| AMPD2 | ENST00000526301.6 | TSL:1 | n.1270C>T | non_coding_transcript_exon | Exon 10 of 18 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152152Hom.: 2 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000557 AC: 14AN: 251258 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000568 AC: 83AN: 1461734Hom.: 0 Cov.: 34 AF XY: 0.0000454 AC XY: 33AN XY: 727176 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000144 AC: 22AN: 152270Hom.: 2 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74450 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 63;C4014354:Pontocerebellar hypoplasia type 9 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 457 of the AMPD2 protein (p.Arg457Trp). This variant is present in population databases (rs373128067, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with AMPD2-related conditions. ClinVar contains an entry for this variant (Variation ID: 574248). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at